Back to BlackRock, Inc. BlackRock, Inc.

ORMPORMP
6 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ORAMED PHARMACEUTICALS INC

BlackRock, Inc. holds 92,192 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $313,453 as of 2026-Q1. The position was increased (+2.2% shares).

Current Value

$313,453

Current Shares

92,192

Total Value Change

+$86,687

Total Shares Change

-1,513

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
92,192
+2.2%
$313,4530.0%$3.38
16
2025-Q4
Decreased
90,212
-17.8%
$257,1040.0%$2.62
0
2025-Q3
Increased
109,733
+28.2%
$289,6960.0%$2.52
20
2025-Q2
Decreased
85,570
-7.3%
$192,5320.0%$2.00
0
2025-Q1
Decreased
92,324
-1.5%
$197,5730.0%$2.06
0
2024-Q4
New
93,705
-
$226,7660.0%$2.17
35

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used